Pacira BioSciences to Join Fireside Chat at 2024 Jefferies Global Healthcare Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX), a leader in non-opioid pain management, will be participating in an analyst-led discussion at the 2024 Jefferies Global Healthcare Conference. This event is scheduled to take place in New York at 11:00 AM ET on Thursday, June 6, 2024. Interested parties can listen to the live audio broadcast by navigating to the “Events” section on the company’s investor relations webpage. For those unable to attend the live session, a replay will be accessible for two weeks following the event.

Pacira BioSciences is dedicated to minimizing the use of opioids in pain management, offering non-opioid options to patients. The company's portfolio includes three key commercial-stage products designed to provide effective pain relief without the use of opioids. These products aim to redefine the role of opioids, relegating them to a backup option rather than a primary treatment.

The first product, EXPAREL® (bupivacaine liposome injectable suspension), is a long-acting local anesthetic. It is sanctioned for several applications, including infiltration, fascial plane block, and as an interscalene brachial plexus nerve block to manage postsurgical pain. By providing sustained pain relief, EXPAREL® helps reduce the need for opioids following surgery, promoting a faster recovery and improving patient outcomes.

Another innovative product is ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release injection designed to manage osteoarthritis knee pain. ZILRETTA® offers prolonged pain relief, helping patients maintain mobility and quality of life without relying on opioids. This treatment provides a valuable option for those suffering from chronic knee pain, offering sustained relief with fewer injections.

Additionally, Pacira markets ioveraº®, a cutting-edge handheld device that delivers immediate, long-lasting pain relief using cold-induced nerve block technology. By administering precise and controlled doses of cold temperature to targeted nerves, ioveraº® provides effective pain control without the use of drugs. This device represents a significant advancement in non-opioid pain management, offering patients a drug-free alternative for managing their pain.

Pacira’s commitment to reducing opioid dependence aligns with their broader mission to redefine pain management practices. By offering a suite of non-opioid solutions, the company aims to provide effective pain relief while minimizing the risks associated with opioid use. This approach not only enhances patient safety but also addresses the growing concern of opioid addiction and misuse.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!